Benitec Biopharma Stock Analysis & Ratings
167 Followers
BNTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.67 - $4.78
Previous Close$0.85
Volume50.70K
Average Volume (3M)2.30M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-0.4
Beta1.09
Next EarningsSep 28, 2022
EPS Forecast-$0.28
Last Dividend Ex-DateJun 01, 2018
Dividend YieldN/A
1Y Price Target$10.00
Smart ScoreN/A
EPS (TTM)-2.10
Shares Outstanding8,171,690
R-Squared0.10
Standard Deviation0.22
10 Day Avg. Volume69,709
30 Day Avg. Volume2,299,193
P/B Ratio0.94
P/S Ratio98.99
P/CF Ratio2.80
P/FCF Ratio-0.60
Total Debt$194.00K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside1073.02% Upside
Rating ConsensusModerate Buy
Alpha-0.04
Number of Analyst Covering1
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNTC FAQ
What was Benitec Biopharma’s price range in the past 12 months?
Benitec Biopharma lowest stock price was $0.67 and its highest was $4.78 in the past 12 months.
What is Benitec Biopharma’s market cap?
Currently, no data Available
What is Benitec Biopharma’s price target?
The average price target for Benitec Biopharma is $10.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $10.00. The average price target represents 1073.02% Increase from the current price of $0.853.
The highest analyst price target is $10.00 ,the lowest forecast is $10.00. The average price target represents 1073.02% Increase from the current price of $0.853.
What do analysts say about Benitec Biopharma?
Benitec Biopharma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
When is Benitec Biopharma’s upcoming earnings report date?
Benitec Biopharma’s upcoming earnings report date is Sep 28, 2022 which is in 45 days.
How were Benitec Biopharma’s earnings last quarter?
Benitec Biopharma released its earnings results on May 16, 2022. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.44 by $0.04.
Is Benitec Biopharma overvalued?
According to Wall Street analysts Benitec Biopharma’s price is currently Undervalued.
Does Benitec Biopharma pay dividends?
Benitec Biopharma pays a Notavailable dividend of $0.03 which represents an annual dividend yield of N/A. Benitec Biopharma’s last Notavailable dividend payment was on Jun 08, 2018. Benitec Biopharma’s upcoming ex-dividend date is Jun 01, 2018
What is Benitec Biopharma’s EPS estimate?
Benitec Biopharma’s EPS estimate is -$0.28.
How many shares outstanding does Benitec Biopharma have?
Benitec Biopharma has 8,171,690 shares outstanding.
What happened to Benitec Biopharma’s price movement after its last earnings report?
Benitec Biopharma reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.44. Following the earnings report the stock price went down -8.475%.
Which hedge fund is a major shareholder of Benitec Biopharma?
Currently, no hedge funds are holding shares in BNTC
---
Benitec Biopharma Stock Analysis
Smart ScoreNot Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Forecast
Moderate Buy
Average Price Target: $10.00
Blogger Sentiment
N/A
Currently Not Enough Data Available
Hedge Fund Holdings
N/A
Currently Not Enough Data Available
Insider Transactions
N/A
Currently Not Enough Data Available
Retail Investors
Very Negative
Last 7 Days ▼ 1.0% Last 30 Days ▼ 5.6%
News Sentiment
N/A
Currently Not Enough Data Available
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.48%
12-Months-Change
Fundamentals
Return on Equity
-185.84%
Trailing 12-Months
Asset Growth
-25.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Benitec Biopharma Ltd
Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in North Sydney, Australia.
---
---